Literature DB >> 10513290

Genotypic and antigenic characterization of hemagglutinin proteins of African measles virus isolates.

A T Truong1, S Kreis, W Ammerlaan, H K Hartter, F Adu, S A Omilabu, A O Oyefolu, G A Berbers, C P Muller.   

Abstract

A comprehensive phylogenetic study based on the hemagglutinin (H) protein of all known African measles virus (MV) isolates is presented. The study includes 64 new H gene sequences from Ghana. Nigeria and South Africa as well as viruses from Zambia and The Gambia for which only incomplete sequencing data were available and that have previously not been genotyped. The results provide further support to the tentative assignment of the Nigerian and Ghanaian viruses to a new genotype B3 within clade B. A distinct geographic distribution pattern emerged with clade B viruses circulating exclusively in African countries north of the equator. All MV strains from southern Africa grouped in clades A and D with the majority of viruses belonging to genotype D4. The viruses considerably differed by their sensitivity to neutralization by monoclonal antibodies (mAb), but three selected antibodies were sufficient to distinguish between African MVs representing four different genotypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10513290     DOI: 10.1016/s0168-1702(99)00072-6

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

Review 1.  Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras.

Authors:  Michaela A Riddell; Jennifer S Rota; Paul A Rota
Journal:  Virol J       Date:  2005-11-22       Impact factor: 4.099

2.  Measles virus genotyping by nucleotide-specific multiplex PCR.

Authors:  Jacques R Kremer; Fred Fack; Christophe M Olinger; Mick N Mulders; Claude P Muller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  New measles genotype, Uganda.

Authors:  Apollo Muwonge; Miriam Nanyunja; Paul A Rota; Josephine Bwogi; Luis Lowe; Stephanie L Liffick; William J Bellini; Sempala Sylvester
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

4.  Evidence of recombination among early-vaccination era measles virus strains.

Authors:  Mikkel H Schierup; Carl H Mordhorst; Claude P Muller; Laurids S Christensen
Journal:  BMC Evol Biol       Date:  2005-10-06       Impact factor: 3.260

5.  Molecular characterisation of virus in the brains of patients with measles inclusion body encephalitis (MIBE).

Authors:  Diana R Hardie; Christine Albertyn; Jeannine M Heckmann; Heidi E M Smuts
Journal:  Virol J       Date:  2013-09-12       Impact factor: 4.099

6.  Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins.

Authors:  Miguel Ángel Muñoz-Alía; Rebecca A Nace; Lianwen Zhang; Stephen J Russell
Journal:  Cell Rep Med       Date:  2021-03-30

7.  Molecular epidemiology of measles viruses in the United States, 1997-2001.

Authors:  Paul A Rota; Stephanie L Liffick; Jennifer S Rota; Russell S Katz; Susan Redd; Mark Papania; William J Bellini
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

8.  High genetic diversity of measles virus, World Health Organization European Region, 2005-2006.

Authors:  Jacques R Kremer; Kevin E Brown; Li Jin; Sabine Santibanez; Sergey V Shulga; Yair Aboudy; Irina V Demchyshyna; Sultana Djemileva; Juan E Echevarria; David F Featherstone; Mirsada Hukic; Kari Johansen; Bogumila Litwinska; Elena Lopareva; Emilia Lupulescu; Andreas Mentis; Zefira Mihneva; Maria M Mosquera; Mark Muscat; M A Naumova; Jasminka Nedeljkovic; Ljubov S Nekrasova; Fabio Magurano; Claudia Fortuna; Helena Rebelo de Andrade; Jean-Luc Richard; Alma Robo; Paul A Rota; Elena O Samoilovich; Inna Sarv; Galina V Semeiko; Nazim Shugayev; Elmira S Utegenova; Rob van Binnendijk; Lasse Vinner; Diane Waku-Kouomou; T Fabian Wild; David W G Brown; Annette Mankertz; Claude P Muller; Mick N Mulders
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.